Oncology Journal Issues Research Articles in June 2024 Edition
June 21, 2024
June 21, 2024
CHICAGO, Illinois, June 21 -- JAMA Oncology, an international peer-reviewed journal for scientists, clinicians and trainees in the field of oncology from the American Medical Association, published research articles on the following topics in its June 2024 edition (Vol. 10, No. 6):
Original Investigation:
* FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 17 . . .
Original Investigation:
* FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 17 . . .